====== Calcium Channel Blockers Education Links ======

|**File Name** |**File Type** |**Audience** |**Previous Use** |**Year Created** |**Country of Origin** |**Associated Files** |**Submitted by** |
|{{:wikitox:calcium_channel_blockers_acem_2003.ppt|Calcium channel blockers ACEM 2003.ppt}}  [41 KB]|PPT| | |2003| | |Ian Whyte|
|{{:wikitox:ccb_cases.ppt|CCB_cases.ppt}}  [177 KB]|PPT| | |2003| | |Ian Whyte|
|{{:wikitox:cardiac_contractility.ppt|Cardiac contractility.ppt}}  [2.7 MB]|PPT| |NewYork PCC|2006|USA| |Dapo Odujebe|
|{{:wikitox:sevilla_insulin_3.pdf|Sevilla Insulin 3.pdf}}  [3.9 MB]|PDF of a PPT| |EEAPCCT 2008|2008|Belgium| |Phillipe Hanston|
|{{:wikitox:ccb_new_york.ppt|CCB New York.ppt}}  [849 KB]|PPT| | | | | |Rama Rao|
| | | | | | | | |

===== ADDITIONAL REFERENCE =====

Brassard E, Archambault P, Lacombe G, St-Onge M. Barriers and Facilitators of Intensivists' Adherence to Hyperinsulinemia-Euglycemia Therapy in the Treatment of Calcium Channel Blocker Poisoning. //J Med Toxicol// 2018 doi: 10.1007/s13181-018-0676-2 [[https://www.ncbi.nlm.nih.gov/pubmed/30047044|PMID 30047044]]

\\